A Randomized Controlled Trial on the Impact of Early Application of CRRT on the Outcomes of Burn Patients With Early Phase of Sepsis

Southwest Hospital, China1 site in 1 country60 target enrollmentDecember 2011

ConditionsBurns Sepsis

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Burns
Sponsor: Southwest Hospital, China
Enrollment: 60
Locations: 1
Primary Endpoint: Changes in serum cytokine concentrations and clearance
Last Updated: 14 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this study is to determine if early application of CRRT will result in an improvement of clinical outcomes of burn patients during the early phase of sepsis

Detailed Description

The impact of Continuous Renal Replacement Therapy (CRRT) on the outcomes of patients with sepsis is controversial, and there is no consensus for the timing and dose of CRRT may improve the outcomes. The purpose of this prospective randomized study is to assess the effect of different CRRT intensity (25ml/kg/h or 50ml/kg/h) on the outcomes of burn patients with early phase of sepsis

Registry

clinicaltrials.gov

Start Date

December 2011

End Date

December 2013

Last Updated

14 years ago

Study Type

Interventional

Study Design

Parallel

Sex

All

Investigators

Sponsor

Southwest Hospital, China

Responsible Party

Principal Investigator

Zhiqiang Yuan

Associate Professor

Southwest Hospital, China

Eligibility Criteria

Inclusion Criteria

•patients with documented sepsis
•clinically identified focus of infection associated with at least 2 SIRS -criteria and one or more sepsis-induced organ failures within the 24 hours -prior to inclusion
•age 18 to 70 years
•severe burned patients with 50% \< TBSA \< 85%

Exclusion Criteria

•cirrhosis child class C
•too high APACHE II \& SOFA score at admission
•age over 70 years
•were presence of a malignant tumor, chronic renal insufficiency (serum creatinine \> 133 µmol/L), moribund state, receiving immunosuppressive therapy or receiving any kind of renal replacement therapy before randomization